• Deferasirox Fe3+ Chelate: Mechanistic Depth and Assay Design

  2026-04-30

  Explore Deferasirox Fe3+ chelate as a research-grade iron chelator for advanced iron overload treatment research. This article provides a mechanistic deep-dive, actionable protocol guidance, and unique assay design perspectives not found in other resources.

• PreScission Protease (PSP): Enabling Native Protein Recovery

  2026-04-30

  Explore how PreScission Protease empowers high-fidelity fusion tag cleavage and native protein recovery, with a focus on its unique enzymology and impact on condensate biology. This in-depth article advances beyond standard reviews to guide optimal assay design using PSP.

• Practical Guide: Benzyl-activated Streptavidin Magnetic Bead

  2026-04-29

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide a robust solution for isolating and purifying biotinylated molecules in protein, nucleic acid, and cell-based assays where specificity and minimal background are essential. These beads are not suitable for workflows requiring covalent linkage of target molecules or for assays incompatible with hydrophobic bead matrices. Consider protocol details and workflow compatibility before integrating into new applications.

• Nystatin (Fungicidin): Optimizing Antifungal Assays in Resea

  2026-04-29

  Nystatin (Fungicidin) from APExBIO empowers researchers with reliable, ergosterol-targeted antifungal action and workflow flexibility, making it indispensable for Candida and Aspergillus studies. Discover protocol enhancements, troubleshooting strategies, and data-driven insights that set this polyene antibiotic apart in advanced mycology and cell-based models.

• Annexin V-FITC/PI Apoptosis Assay Kit: Technical Protocol Gu

  2026-04-28

  The Annexin V-FITC/PI Apoptosis Assay Kit enables rapid, stage-specific discrimination of apoptotic and necrotic cells using dual staining compatible with flow cytometry or fluorescence microscopy. It is best used for research applications requiring clear separation of viable, early apoptotic, and late apoptotic/necrotic cell populations. This kit should not be used for diagnostic or clinical decision-making.

• Applied Insights: Fasudil (HA-1077) HCl as a Selective ROCK

  2026-04-28

  Fasudil (HA-1077) HCl empowers researchers with precise Rho/ROCK pathway inhibition for dissecting cell proliferation, migration, and apoptosis, especially in oncology and disease modeling. This article translates cutting-edge workflows and troubleshooting tips into actionable strategies, highlighting how APExBIO’s robust reagent elevates experimental reproducibility and cross-pathway discovery.

• Ademetionine (SAMe) in Neurological Disorders: Methylation I

  2026-04-27

  This review by Bottiglieri et al. synthesizes evidence on S-adenosylmethionine (SAMe) as a pivotal methyl donor in CNS function, highlighting its biochemical roles and clinical potential in treating depression, dementia, and other neurological disorders. The article integrates mechanistic insights and early clinical findings, providing a foundation for targeted methylation research.

• Naloxone Hydrochloride: Precision Opioid Receptor Antagonist

  2026-04-27

  Naloxone hydrochloride empowers researchers to dissect opioid receptor pathways, neural stem cell modulation, and behavioral paradigms with unmatched purity and reproducibility. APExBIO’s formulation ensures reliable outcomes in opioid receptor antagonist studies, optimizing every step from cell-based assays to in vivo models.

• FABP4 Inhibition: Redefining Translational Atherosclerosis R

  2026-04-26

  Explore how selective inhibition of FABP4, particularly with BMS 309403, is transforming the mechanistic and translational landscape of atherosclerosis and metabolic disease research. This thought-leadership article synthesizes the latest mechanistic insights, protocol strategies, and clinical perspectives, providing actionable guidance for researchers aiming to bridge basic discovery with therapeutic innovation.

• Calpeptin: Potent Calpain Inhibitor for Fibrosis Research

  2026-04-25

  Calpeptin is a nanomolar-potency calpain inhibitor, widely applied in pulmonary fibrosis research for its ability to modulate fibrosis and inflammation pathways. Its specificity for calpain 1 and robust inhibition profile make it a standard tool for dissecting cell death and remodeling mechanisms in vitro and in vivo.

• TCAIM Regulates Mitochondrial Metabolism via OGDH Degradatio

  2026-04-24

  Wang et al. (2025) reveal that the mitochondrial co-chaperone TCAIM specifically binds and reduces the protein levels of a-ketoglutarate dehydrogenase (OGDH), modulating the TCA cycle and cellular metabolism. This study uncovers a distinct, post-translational regulatory mechanism for mitochondrial enzymes, with implications for metabolic research and disease modeling.

• MK-1775: Applied Workflows for Wee1 Kinase Inhibition in Can

  2026-04-24

  Unlock the power of MK-1775 (Wee1 kinase inhibitor) to drive cell cycle checkpoint abrogation and enhance the sensitivity of p53-deficient tumor cells in DNA damage response assays. This article delivers advanced experimental workflows, troubleshooting insights, and actionable parameters—grounded in recent literature—to maximize reproducibility and data clarity in translational oncology.

• GANT61 Induces Apoptosis in ALK+ ALCL via Hh-PIK3IP1-Akt Mod

  2026-04-23

  This study demonstrates that GANT61, a Hedgehog pathway inhibitor, effectively suppresses proliferation and induces apoptosis in ALK-positive anaplastic large cell lymphoma (ALK+ ALCL) by modulating the Hh-PIK3IP1-Akt signaling axis. The findings reveal mechanistic insight into Gli1 inhibition and its downstream effects, highlighting potential therapeutic strategies for ALK+ ALCL.

• Advanced In Vitro Assays to Decipher Cancer Drug Responses

  2026-04-23

  Schwartz's dissertation establishes a refined framework for evaluating anti-cancer drug responses in vitro, distinguishing between proliferative arrest and cell death. This approach enables more precise assessment of drug effects, with significant implications for optimizing targeted therapies and chemosensitization strategies.

• Dual Enzyme-Responsive Zwitterionic Peptides for Cancer Sele

  2026-04-22

  This study presents a zwitterionic peptide amphiphile engineered for high cancer selectivity through dual enzyme-responsiveness, enabling intralysosomal self-assembly and selective cancer cell death. The approach markedly improves therapeutic index and specificity, addressing a longstanding challenge in peptide-based cancer therapeutics.

16158 records 1/1078 page Next 12345 下5页 Last page